REGN
Regeneron Pharmaceuticals Inc
Price:  
982.82 
USD
Volume:  
368,580.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Relative Valuation

-41.3%
Upside

As of 2024-03-02, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 576.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 982.82 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -41.3%.

The range of the Relative Valuation is 490.90 - 666.38 USD.

Range Selected
Trailing P/E multiples 14.2x - 18.5x 16.4x
Forward P/E multiples 13.4x - 17.4x 15.4x
Fair Price 490.90 - 666.38 576.55
Upside -50.1% - -32.2% -41.3%
982.82 USD
Stock Price
576.55 USD
Fair Price

Regeneron Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 27.29
2024-02-29 26.82
2024-02-28 27.42
2024-02-27 27.58
2024-02-26 27.46
2024-02-23 27.24
2024-02-22 26.79
2024-02-21 26.45
2024-02-20 26.29
2024-02-16 26.32
2024-02-15 26.51
2024-02-14 26.31
2024-02-13 26.11
2024-02-12 26.29
2024-02-09 26.47
2024-02-08 26.27
2024-02-07 26.05
2024-02-06 26.04
2024-02-05 25.99
2024-02-02 26.24
2024-02-01 26.59
2024-01-31 26.17
2024-01-30 26.64
2024-01-29 26.53
2024-01-26 26.10
2024-01-25 26.34
2024-01-24 26.33
2024-01-23 26.50
2024-01-22 26.17
2024-01-19 25.91
2024-01-18 25.82
2024-01-17 25.79
2024-01-16 26.02
2024-01-12 25.91
2024-01-11 25.43
2024-01-10 25.16
2024-01-09 25.06
2024-01-08 25.07
2024-01-05 25.35
2024-01-04 25.32
2024-01-03 25.47
2024-01-02 25.12
2023-12-29 24.38
2023-12-28 24.48
2023-12-27 24.27
2023-12-26 23.58
2023-12-22 23.51
2023-12-21 23.37
2023-12-20 23.37
2023-12-19 23.55